Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature Review

Neonatal hyperbilirubinemia is a frequently observed clinical situation that, sometimes, may result in complications ranging from mild neurodevelopment impairment to serious outcome of kernicterus. The rationale logic of heme oxygenase enzyme inhibition to lower bilirubin levels is intriguing. In co...

Full description

Saved in:
Bibliographic Details
Main Authors: Prakar Poudel, Sudhir Adhikari
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Pediatrics
Online Access:http://dx.doi.org/10.1155/2022/2549161
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565323176345600
author Prakar Poudel
Sudhir Adhikari
author_facet Prakar Poudel
Sudhir Adhikari
author_sort Prakar Poudel
collection DOAJ
description Neonatal hyperbilirubinemia is a frequently observed clinical situation that, sometimes, may result in complications ranging from mild neurodevelopment impairment to serious outcome of kernicterus. The rationale logic of heme oxygenase enzyme inhibition to lower bilirubin levels is intriguing. In compliance with that rationale, metalloporphyrin was discovered. After successful results in in-vitro and animal studies, tin mesoporphyrin is now under phase II clinical trial to test for preventive and therapeutic efficacy in unconjugated hyperbilirubinemia. This review evaluates in-vitro studies, animal studies, and clinical trials for the efficacy and safety of tin analogues of metalloporphyrin. Few alternatives to metalloporphyrins are also available, synchronizing with the same rationale logic of inhibition of bilirubin production, which need further research.
format Article
id doaj-art-b3af5b6dee624e78a3d253b68279aa5e
institution Kabale University
issn 1687-9759
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Pediatrics
spelling doaj-art-b3af5b6dee624e78a3d253b68279aa5e2025-02-03T01:08:47ZengWileyInternational Journal of Pediatrics1687-97592022-01-01202210.1155/2022/2549161Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature ReviewPrakar Poudel0Sudhir Adhikari1Devghat ClinicDepartment of PediatricsNeonatal hyperbilirubinemia is a frequently observed clinical situation that, sometimes, may result in complications ranging from mild neurodevelopment impairment to serious outcome of kernicterus. The rationale logic of heme oxygenase enzyme inhibition to lower bilirubin levels is intriguing. In compliance with that rationale, metalloporphyrin was discovered. After successful results in in-vitro and animal studies, tin mesoporphyrin is now under phase II clinical trial to test for preventive and therapeutic efficacy in unconjugated hyperbilirubinemia. This review evaluates in-vitro studies, animal studies, and clinical trials for the efficacy and safety of tin analogues of metalloporphyrin. Few alternatives to metalloporphyrins are also available, synchronizing with the same rationale logic of inhibition of bilirubin production, which need further research.http://dx.doi.org/10.1155/2022/2549161
spellingShingle Prakar Poudel
Sudhir Adhikari
Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature Review
International Journal of Pediatrics
title Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature Review
title_full Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature Review
title_fullStr Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature Review
title_full_unstemmed Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature Review
title_short Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature Review
title_sort efficacy and safety concerns with sn mesoporphyrin as an adjunct therapy in neonatal hyperbilirubinemia a literature review
url http://dx.doi.org/10.1155/2022/2549161
work_keys_str_mv AT prakarpoudel efficacyandsafetyconcernswithsnmesoporphyrinasanadjuncttherapyinneonatalhyperbilirubinemiaaliteraturereview
AT sudhiradhikari efficacyandsafetyconcernswithsnmesoporphyrinasanadjuncttherapyinneonatalhyperbilirubinemiaaliteraturereview